<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02350595</url>
  </required_header>
  <id_info>
    <org_study_id>FISK2</org_study_id>
    <nct_id>NCT02350595</nct_id>
  </id_info>
  <brief_title>A Study on the Possible Health Effects of Lean Fish and Fatty Fish Intake in Overweight or Obese Adults</brief_title>
  <acronym>FISK2</acronym>
  <official_title>Fiskespisestudiene 2011-2014. Spiseforsøk Med Fisk. Delstudie 2: Studie av Mulige Effekter av Fet og Mager Fisk på Glukosemetabolismen og inflammasjonsmarkører i Overvektige Voksne.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bergen Medical Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Skretting ASA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leroy Seafood Group ASA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bergen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The potential health effects of high intake of lean or fatty fish will be investigated in
      overweight or obese adults. Participants consume 750g/week of fillets of fish for 8 weeks.

      Hypothesis:

      High intake of fatty or lean fish will beneficially affect glucose regulation and the immune
      system.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in serum concentrations of glucose</measure>
    <time_frame>baseline and 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in insulin, insulin C-peptide, leukocyte fatty acids, leukocyte function, body weight and composition, and intake of energy and macronutrients within the groups over time.</measure>
    <time_frame>baseline and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in serum vitamin concentrations after fish intake.</measure>
    <time_frame>baseline and 8 weeks</time_frame>
    <description>Serum concentrations of fat-soluble and water-soluble vitamins were measured, and dietary intakes of vitamins were estimated based on reported food intake from 5-day food diaries.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in serum and urine concentrations of amino acids and metabolites of amino acids after fish intake.</measure>
    <time_frame>baseline and 8 weeks</time_frame>
    <description>Concentrations of amino acids and amino acid metabolites were measured in fasting serum and morning urine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in fecal microbiota profile after fish intake.</measure>
    <time_frame>baseline and 8 weeks</time_frame>
    <description>54 DNA bacterial markers targeting more than 300 bacteria based on their 16S rRNA sequence in seven variable regions were analysed in feces (72h collection)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in fecal and serum concentrations of lipids and bile acids after fish intake.</measure>
    <time_frame>baseline and 8 weeks</time_frame>
    <description>Fat, cholesterol and total bile acids were quantified in feces (72h collection) and fasting serum.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Lean fish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants eat 750g of lean fish per week for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fatty fish</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants eat 750g of fatty fish per week for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants eat as normal, but avoid fish and seafood for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lean fish</intervention_name>
    <arm_group_label>Lean fish</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fatty fish</intervention_name>
    <arm_group_label>Fatty fish</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI ≥27 kg/m2

          -  fasting blood glucose ≤7.0 mmol/L

        Exclusion Criteria:

          -  pregnancy

          -  incompatibility with fish consumption (allergies, intolerance and/or dislike)

          -  diagnosed diabetes mellitus, heart disease or gastrointestinal diseases

          -  use of medications affecting lipid metabolism or glucose homeostasis

          -  use of anti-inflammatory medications

          -  use of supplements containing long chain n-3 fatty acids

          -  intentional weight loss

          -  and large fluctuation in body weight (&gt;3 kg) over the previous two months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Helland A, Bratlie M, Hagen IV, Mjøs SA, Sørnes S, Ingvar Halstensen A, Brokstad KA, Sveier H, Rosenlund G, Mellgren G, Gudbrandsen OA. High intake of fatty fish, but not of lean fish, improved postprandial glucose regulation and increased the n-3 PUFA content in the leucocyte membrane in healthy overweight adults: a randomised trial. Br J Nutr. 2017 May;117(10):1368-1378. doi: 10.1017/S0007114517001234. Epub 2017 Jun 13.</citation>
    <PMID>28606215</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 26, 2015</study_first_submitted>
  <study_first_submitted_qc>January 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2015</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bergen</investigator_affiliation>
    <investigator_full_name>Oddrun Anita Gudbrandsen</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

